Schonfeld Strategic Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$108K	Buy
2025 Q1	–	Sell
2024 Q4	$368K	Buy
2023 Q1	–	Sell
2022 Q4	$626K	Sell
2022 Q3	$1.24M	Sell
2022 Q2	$1.4M	Buy
2022 Q1	$650K	Buy